Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentostatin in Steroid Refractory Acute GVHD
NCT00201786Phase 2Completed
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Jul 2003
- Primary completion
- Oct 2007
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of pentostatin in Acute Graft-Versus-Host Disease (aGvHD), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Started Jul 2003; status: completed.
02
Drugs
pentostatin
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT00201786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00201786.